Nifty Pharma Prediction for Monday, 13 July 2026: Index Nearly Flat at 25,674.10 as Defensives Lag

Nifty Pharma prediction for Monday 13 July 2026: index at 25,674.10, up 0.07 percent on Friday. Support 25,450. Resistance 25,800 and 26,000.

Updated: 10 Jul 2026 • 5:19 pm

Posted by:

Nifty Pharma Prediction for Monday, 13 July 2026: Index Nearly Flat at 25,674.10 as Defensives Lag

Nifty pharma prediction for monday: Nifty Pharma closed at 25,674.10 on Friday, up just 17.85 points or 0.07 percent, a near-flat session that made it one of the weakest sectoral performers as cyclicals like PSU banks and realty dominated the day's flows. This nifty pharma prediction for monday is built on Friday, 10 July 2026's closing data, the last completed session before markets reopen on Monday, 13 July 2026.

Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Nifty Pharma prediction for Monday reflects a classic defensive-sector pause during a risk-on rally, with the index holding steady rather than declining, which he reads as a sign of underlying resilience even without active buying interest.

Click Here – Get Free Investment Predictions

Table of Contents

Market Recap Behind the Nifty pharma prediction for monday

The index opened at 25,681.70, touched a high of 25,779.40 and a low of 25,444.20 before closing at 25,674.10, essentially unchanged. Ankit Jaiswal notes that pharma's stability, rather than an outright decline, suggests the sector isn't being actively sold, just overshadowed by stronger flows into PSU banks and realty.

Nifty pharma prediction for monday: Trend and Key Levels

Trend: Sideways Between 25,450 and 25,800

Level Type	Value
Support 1	25,450
Support 2	25,300
Resistance 1	25,800
Resistance 2	26,000

Ankit Jaiswal flags 25,450 as the key support, with 25,800 as the near-term resistance. A close above 26,000 would suggest pharma is regaining favour, while a break under 25,300 would signal the sector is beginning to see active selling rather than mere underperformance.

Global Cues for Nifty Pharma on Monday

Reports that Iran reached out to Washington for talks lifted global sentiment on Friday, Asian markets surged with the Kospi up 4.47 percent, and Wall Street rose on a chip-stock rally. Brent crude eased to near 76 dollars a barrel but is still headed for a weekly gain near 6 percent. Pharma is largely insulated from these geopolitical and currency-driven cues, since the sector's fortunes depend more on US generic pricing trends and domestic demand than on Middle East headlines or metal prices.

Key Triggers in the Nifty pharma prediction for monday

These triggers dominate the outlook heading into Monday, 13 July 2026:

US generic pricing developments: Any regulatory or pricing news from the US market remains the clearest sector-specific catalyst.
Sector rotation reversal: A pause in the current PSU bank and realty rally could see money rotate back into defensives like pharma.
HCL Technologies reports Q1 FY27 results on Monday 13 July itself, with the market reaction landing on Tuesday.

Talk to a SEBI Registered Investment Advisor Before Your Next Trade

Stocks to Watch in the Pharma Sector

Key pharma constituents worth tracking alongside the broader sector outlook.

Sun Pharma: Sun Pharma is a sector bellwether worth tracking for stock-level signals within the pharma space.

Nifty Healthcare: The closely related healthcare index moved in a similarly muted fashion on Friday.

Risks to the Nifty pharma prediction for monday

These factors can invalidate this outlook:

Continued cyclical rotation: If PSU banks and realty keep leading, pharma could see further muted or negative relative performance.
US regulatory setback: Any adverse FDA decision would be a clear sector-specific negative.
Currency moves: A stronger rupee would reduce the value of pharma's dollar-denominated export earnings.

Download the Univest iOS App or Univest Android App to track live Nifty Pharma levels and get daily research from SEBI registered analysts.

Conclusion

The Nifty Pharma prediction for Monday, 13 July 2026, is sideways between 25,450 and 25,800, after the index stayed essentially flat on Friday amid a cyclical-led broader rally. Ankit Jaiswal flags 25,450 as the key support in the Nifty Pharma prediction for Monday, with US generic pricing news and a potential rotation reversal the key variables heading into the new week.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty pharma prediction for monday

What is the Nifty Pharma prediction for Monday, 13 July 2026?

Ans. The Nifty Pharma prediction for Monday, 13 July 2026, is sideways between 25,450 and 25,800. The index closed at 25,674.10 on Friday, up just 0.07 percent, as cyclicals dominated the session instead.

Which analyst gave the Nifty Pharma prediction for Monday?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest, has shared the Nifty Pharma prediction for Monday, flagging 25,450 as the key support level.

Why did Nifty Pharma stay nearly flat on Friday?

Ans. Nifty Pharma rose just 0.07 percent on Friday as money flowed into PSU banks and realty instead. The Nifty Pharma prediction for Monday reads this as sector rotation rather than active selling, since the index held steady rather than declining.

What would improve the Nifty Pharma prediction for Monday's outlook?

Ans. A pause in the current PSU bank and realty-led rally, which would allow money to rotate back into defensives like pharma, or positive US generic pricing news, would be the clearest catalysts for pharma outperformance.